None listed
Conditions
Interventions
Procedure/Surgery : 1. Experimental group
Pharmacopuncture therapy
-Based on the clinical judgment of a Korean Medicine Doctor who considers the lesion of stenosis, symptom area, and tender point, the following sites and methods are selective
Conventional Physical Therapy (TENS
Microwave)
- Transcutaneous Electrical Nerve Stimulation : Attach two pads on both sides of the lumbar spine considering the levels of spinal stenosis lesions. Apply low-frequency (20Hz) and high-inte
Sponsors
Pusan National University Korean Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) aged 40 years and older but younger than 75 years 2) confirmed to have lumbar spinal stenosis on imaging examination (CT or MRI) - In cases where there is no existing imaging data or re-imaging is necessary, L-spine CT examination will be performed 3) pain or discomfort in the lumbar, lower limb, or buttock = VAS 40mm 4) Individuals who have clinical manifestations of lumbar spinal stenosis, such as neurogenic claudication or symptoms that change with posture 5) Individuals who have received a final diagnosis of lumbar spinal stenosis based on comprehensive physical examination, medical history, and imaging examination results 6) Individuals who voluntarily decide to participate after being informed of the study purpose and procedure and provide written informed consent
Exclusion criteria
Exclusion criteria: 1) Individuals diagnosed with congenital or developmental lumbar spinal stenosis 2) Individuals diagnosed with spinal disorders other than lumbar spinal stenosis, which may cause lower back pain and radiating pain (e.g., vertebral tumors, Cauda equina syndrome, spinal infections, ankylosing spondylitis) 3) Individuals with lower extremity arterial stenosis or occlusion that can induce claudication 4) Individuals with major structural issues of the spine (acute thoracolumbar vertebral fracture, spinal dislocation, spondylolisthesis) 5) Individuals with a history of spinal surgery, such as spinal fusion or laminectomy 6) Individuals with acupuncture hypersensitivity, metal allergies, severe atopic dermatitis, keloid skin, or other skin hypersensitivity 7) Individuals with chronic diseases (e.g., chronic kidney disease, diabetic neuropathy, stroke and myocardial infarction, dementia, epilepsy) that may affect treatment outcomes or research results 8) Individuals taking medications (e.g., steroids, immunosuppressants) that may affect treatment outcomes or research results 9) Individuals with significant neuropsychiatric medical history or current illness 10) Individuals with a history of alcoholism or drug abuse 11) Pregnant or lactating women or those planning to become pregnant 12) Individuals who are unable to self-report consent/data or require assistance from a caregiver/researcher to do so 13) Other individuals deemed inappropriate by the clinical research coordinator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment (Adverse effect);Visual analog scale (VAS);Zurich claudication questionaire (ZCQ) : ZCQ-symptom score, ZCQ-function score (Assessment for Symptom & Functional disability);Roland-Morris disability questionnaire (RMDQ) (Assessment for lumbar functional disability);Maxium walking distance;EuroQol-5D-5L (EQ-5D-5L) ;Patient Global Impression of change (PGIC) | — |
Countries
Korea, Republic of
Contacts
Public ContactEunseok Kim
Pusan National University Korean Medicine Hospital
Outcome results
None listed